本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

3.20
+0.09002.89%
盤後3.200.00000.00%19:59 EDT
成交量:381.98萬
成交額:1,217.75萬
市值:6.21億
市盈率:-4.21
高:3.23
開:3.14
低:3.11
收:3.11
52周最高:6.44
52周最低:2.56
股本:1.94億
流通股本:1.64億
量比:0.71
換手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:1.31
市盈率(LYR):-3.20

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/30

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/09/29

重要事件披露

Form 8-K - Current report
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/27

重要事件披露

8-K - Current report
2023/03/21

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals